TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients (THRIVE-65)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05535192 |
Recruitment Status :
Recruiting
First Posted : September 10, 2022
Last Update Posted : April 5, 2024
|
Sponsor:
Dana-Farber Cancer Institute
Collaborators:
National Cancer Institute (NCI)
Case Western Reserve University
University of Pittsburgh
Information provided by (Responsible Party):
Jennifer A. Ligibel, MD, Dana-Farber Cancer Institute
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | September 30, 2026 |
Estimated Study Completion Date : | February 1, 2027 |